We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AptarGroup Grows on Strategic Moves & Strong Pharma Business
Read MoreHide Full Article
On Feb 20, we issued an updated research report on AptarGroup, Inc. (ATR - Free Report) . The company is poised to gain from its focus on strategies and business-transformation plan. Its Pharma business will benefit from drug delivery innovation.
Let’s illustrate these growth factors in detail.
AptarGroup to Gain From Focus on Strategies
AptarGroup projects earnings per share for first-quarter 2018 in the range of 90-95 cents, reflecting year-over-year growth of 1.6% at the mid-point. The company expects each segment to report elevated first-quarter revenues over the prior year. The outlook is backed by its focus on strategies, including transformation activities in the Beauty + Home segment and select G&A functions.
Business-Transformation Plan to Fuel Growth
In late 2017, AptarGroup began a business-transformation plan in a bid to become a more agile, competitive and customer-centric business. This plan includes a wide range of initiatives to drive sales growth, enhance operational excellence, and improve organizational health and effectiveness. AptarGroup is poised to gain from its focus on the plan which will yield annual recurring incremental EBITDA of approximately $80 million by the end of 2020.
Pharma Business Remains a Tailwind
AptarGroup’s Pharma segment will continue to improve on the back of drug delivery innovation. The company also remains focused on partnering with customers to supply extraordinary medicines and treatments. Further, it has invested in additional capacity at its Congers, NY facility to better serve U.S. customers in the injectables market.
Share Price Performance
AptarGroup has outperformed its industry with respect to price performance over the past year. The stock has gained around 22.7%, while the industry has recorded growth of 7.6% during the same time frame.
Zacks Rank & Other Stocks to Consider
AptarGroup currently carries a Zacks Rank #2 (Buy).
Graphic Packaging has a long-term earnings growth rate of 5%. Its shares have rallied 14.4%, over the past six months.
Packaging Corporation of America has a long-term earnings growth rate of 8.3%. The company’s shares have been up 9.3% during the same time frame.
Bemis has a long-term earnings growth rate of 10.3%. The stock has gained 9.1% in six months’ time.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation. See Them Free>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
AptarGroup Grows on Strategic Moves & Strong Pharma Business
On Feb 20, we issued an updated research report on AptarGroup, Inc. (ATR - Free Report) . The company is poised to gain from its focus on strategies and business-transformation plan. Its Pharma business will benefit from drug delivery innovation.
Let’s illustrate these growth factors in detail.
AptarGroup to Gain From Focus on Strategies
AptarGroup projects earnings per share for first-quarter 2018 in the range of 90-95 cents, reflecting year-over-year growth of 1.6% at the mid-point. The company expects each segment to report elevated first-quarter revenues over the prior year. The outlook is backed by its focus on strategies, including transformation activities in the Beauty + Home segment and select G&A functions.
Business-Transformation Plan to Fuel Growth
In late 2017, AptarGroup began a business-transformation plan in a bid to become a more agile, competitive and customer-centric business. This plan includes a wide range of initiatives to drive sales growth, enhance operational excellence, and improve organizational health and effectiveness. AptarGroup is poised to gain from its focus on the plan which will yield annual recurring incremental EBITDA of approximately $80 million by the end of 2020.
Pharma Business Remains a Tailwind
AptarGroup’s Pharma segment will continue to improve on the back of drug delivery innovation. The company also remains focused on partnering with customers to supply extraordinary medicines and treatments. Further, it has invested in additional capacity at its Congers, NY facility to better serve U.S. customers in the injectables market.
Share Price Performance
AptarGroup has outperformed its industry with respect to price performance over the past year. The stock has gained around 22.7%, while the industry has recorded growth of 7.6% during the same time frame.
Zacks Rank & Other Stocks to Consider
AptarGroup currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the same sector are Graphic Packaging Holding Company (GPK - Free Report) , Packaging Corporation of America (PKG - Free Report) and Bemis Company, Inc. . All three stocks carry a Zacks Rank #2. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Graphic Packaging has a long-term earnings growth rate of 5%. Its shares have rallied 14.4%, over the past six months.
Packaging Corporation of America has a long-term earnings growth rate of 8.3%. The company’s shares have been up 9.3% during the same time frame.
Bemis has a long-term earnings growth rate of 10.3%. The stock has gained 9.1% in six months’ time.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
See Them Free>>